Novel lipid mediators contributing to androgen receptor therapy resistance in prostate cancer

por Chinni, Sreenivasa R.
Publicado 2021

Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis

por Wong, Donald, Kandagatla, Pridvi, Korz, Walter, Chinni, Sreenivasa R
Publicado 2014

TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model

por Semaan, Louie, Mander, Navneet, Cher, Michael L., Chinni, Sreenivasa R.
Publicado 2019

PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling

por Conley-LaComb, M Katie, Saliganan, Allen, Kandagatla, Pridvi, Chen, Yong Q, Cher, Michael L, Chinni, Sreenivasa R
Publicado 2013

Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth

por Govindarajan, Barani, Sbrissa, Diego, Pressprich, Mark, Kim, Seongho, Rishi, Arun K., Vaishampayan, Ulka, Cher, Michael L., Chinni, Sreenivasa R.
Publicado 2023

Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis

por Conley-LaComb, M. Katie, Semaan, Louie, Singareddy, Rajareddy, Li, Yanfeng, Heath, Elisabeth I., Kim, Seongho, Cher, Michael L., Chinni, Sreenivasa R.
Publicado 2016

A novel cross-talk between CXCR4 and PI4KIIIα in prostate cancer cells.

por Sbrissa, Diego, Semaan, Louie, Govindarajan, Barani, Li, Yanfeng, Caruthers, Nicholas J., Stemmer, Paul M., Cher, Michael L., Sethi, Seema, Vaishampayan, Ulka, Shisheva, Assia, Chinni, Sreenivasa R.
Publicado 2018

Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity

por Mazzu, Ying Z., Liao, YuRou, Nandakumar, Subhiksha, Sjöström, Martin, Jehane, Lina E., Ghale, Romina, Govindarajan, Barani, Gerke, Travis A., Lee, Gwo‐Shu Mary, Luo, Jian‐Hua, Chinni, Sreenivasa R., Mucci, Lorelei A., Feng, Felix Y., Kantoff, Philip W.
Publicado 2022